Addressing Somatic Mutations for Cell Therapies to Consider How This Could Affect Treatment
Time: 11:30 am
day: Conference Day One
Details:
- Exploring how genetic variations in donor cells can influence the efficacy and safety of iPSC-based therapies
- Evaluating the potential differences in somatic mutation profiles between skin and bloodderived iPSCs, and their implications for treatment outcomes
- Discussing strategies to identify and mitigate potential safety concerns associated with somatic mutations in iPSC-derived cell therapies
